How should new treatments for benign prostatic hyperplasia be assessed?
- 15 May 1993
- Vol. 306 (6888) , 1283-1284
- https://doi.org/10.1136/bmj.306.6888.1283
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- DEVELOPMENTS IN THE PURCHASING PROCESS IN THE NHS: TOWARDS AN EXPLICIT POLITICS OF RATIONING?Public Administration, 1993
- Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial.BMJ, 1993
- Terazosin in the Treatment of Benign Prostatic Hyperplasia: A Multicentre, Placebo‐Controlled TrialPublished by Wiley ,1992
- Medical treatment for benign prostatic hyperplasia.BMJ, 1992
- GENERAL MANAGEMENT IN THE NHS: THE INITIAL IMPACT 1983–88Public Administration, 1991
- Permanently Implanted Urethral Stent for Prostatic Obstruction in the Unfit Patient: Preliminary ReportBritish Journal of Urology, 1990
- Outcome of elective prostatectomy.BMJ, 1989
- A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy.1976